133 related articles for article (PubMed ID: 8344575)
1. Study of the proliferation in human gastric mucosa after in vivo bromodeoxyuridine labelling.
Patel S; Rew DA; Taylor I; Potten CS; Owen C; Roberts SA
Gut; 1993 Jul; 34(7):893-6. PubMed ID: 8344575
[TBL] [Abstract][Full Text] [Related]
2. Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine.
Potten CS; Kellett M; Roberts SA; Rew DA; Wilson GD
Gut; 1992 Jan; 33(1):71-8. PubMed ID: 1740282
[TBL] [Abstract][Full Text] [Related]
3. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa.
Bromley M; Rew D; Becciolini A; Balzi M; Chadwick C; Hewitt D; Li YQ; Potten CS
Eur J Histochem; 1996; 40(2):89-100. PubMed ID: 8839702
[TBL] [Abstract][Full Text] [Related]
4. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
[TBL] [Abstract][Full Text] [Related]
5. Correlation between iododeoxyuridine and MIB-1 labelling index in gastric carcinoma and adjacent normal gastric tissue.
Schipper DL; Wagenmans MJ; Peters WH; Wobbes T; Wagener DJ
Anticancer Res; 2000; 20(2A):707-14. PubMed ID: 10810344
[TBL] [Abstract][Full Text] [Related]
6. Cell proliferation study on gastric carcinoma and non-involved gastric mucosa using a bromodeoxyuridine (BrdU) labelling technique.
Brito MJ; Filipe MI; Morris RW
Eur J Cancer Prev; 1992 Oct; 1(6):429-35. PubMed ID: 1463997
[TBL] [Abstract][Full Text] [Related]
7. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application.
Ohyama S; Yonemura Y; Miyazaki I
Cancer; 1992 Jan; 69(2):314-21. PubMed ID: 1728362
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
[TBL] [Abstract][Full Text] [Related]
10. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli.
Potten CS; Kellett M; Rew DA; Roberts SA
Gut; 1992 Apr; 33(4):524-9. PubMed ID: 1316306
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation in normal and diseased gastric mucosa. Autoradiography after in vitro continuous labelling with tritiated thymidine.
Hart-Hansen O; Johansen A; Larsen JK; Svendsen LB
Acta Pathol Microbiol Scand A; 1979 May; 87A(3):217-22. PubMed ID: 463568
[TBL] [Abstract][Full Text] [Related]
12. Morphology and modes of cell proliferation in earliest signet-ring-cell carcinomas induced in canine stomachs by N-ethyl-N'-nitro-N-nitrosoguanidine.
Sugihara H; Hattori T; Imamura Y; Noriki S; Fukuda M; Katsura K; Tsuchihashi Y; Fujita S
J Cancer Res Clin Oncol; 1991; 117(3):197-204. PubMed ID: 1851763
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of gastric adenoma versus early gastric cancer by bromodeoxyuridine immunohistochemistry from gastric biopsy specimen.
Miwa H; Wada R; Abe H; Ohkura R; Yang SW; Watanabe H; Ogihara T; Hamada T; Sato N
J Gastroenterol Hepatol; 1993; 8(2):133-7. PubMed ID: 8471750
[TBL] [Abstract][Full Text] [Related]
14. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma.
Cahill RJ; Kilgallen C; Beattie S; Hamilton H; O'Morain C
Gut; 1996 Feb; 38(2):177-81. PubMed ID: 8801193
[TBL] [Abstract][Full Text] [Related]
15. Cell kinetic studies in mouse tongue mucosa by autoradiographic, immunohistochemical and flow cytometric techniques.
Dörr W; Arui J; Beisker W; Schultz-Hector S
Cell Prolif; 1994 Jun; 27(6):321-32. PubMed ID: 10465020
[TBL] [Abstract][Full Text] [Related]
16. Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours.
Rew DA; Campbell ID; Taylor I; Wilson GD
Br J Surg; 1992 Apr; 79(4):335-9. PubMed ID: 1576503
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
[TBL] [Abstract][Full Text] [Related]
18. Immediate bromodeoxyuridine labelling of unseparated human bone marrow cells ex vivo is superior to labelling after routine laboratory processing.
Jensen PO; Mortensen BT; Christensen IJ; Larsen JK
Cell Prolif; 1998 Feb; 31(1):1-7. PubMed ID: 9666814
[TBL] [Abstract][Full Text] [Related]
19. A comparison of in vivo cell proliferation measurements in the intestine of mouse and man.
Kellett M; Potten CS; Rew DA
Epithelial Cell Biol; 1992 Oct; 1(4):147-55. PubMed ID: 1307946
[TBL] [Abstract][Full Text] [Related]
20. Cell-proliferative activity and its relationship to the histologic type of early gastric cancer.
Wang Z; Ikeguchi M; Maeta M; Kaibara N
Oncol Rep; 1998; 5(1):191-5. PubMed ID: 9458320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
